PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOONS CATHETER MARKET ANALYSIS

Percutaneous Transluminal Angioplasty Balloons Catheter Market, By Type (Standard PTA Ballons, High Pressure PTA Ballons, Others), By Material Type (Polyurethane, Nylon, Others), By Application (Peripheral Artery Disease and Coronary Artery Disease), By End User (Hospital, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

On August 5, 2024, Teleflex Incorporated, a medical device company, announced that the U.S. Food and Drug Administration had approved its new percutaneous transluminal coronary angioplasty perfusion balloon catheter. The Ringer perfusion balloon catheter features a rapid-exchange design compatible with 0.014” systems and includes a helical balloon that, when inflated, forms a hollow cylinder with a large central lumen, allowing continuous blood flow during extended inflations.
On May 3, 2024, the Swanson School of Engineering at the University of Pittsburgh announced that it had secured approximately US$ 1.1 million from the South Korean Ministry of Health and Welfare as part of its Healthcare Technology Research and Development Project to innovate the design of coronary balloon devices
In March 2021, Medtronic, a medical technology company, announced the launch of its Chameleon percutaneous transluminal angioplasty (PTA) balloon catheter in several countries, including Germany, Italy, Portugal, South Africa, Spain, and Turkey. This device is designed for use in both native and synthetic arteriovenous dialysis fistulae, as well as in femoral, iliac, and renal arteries.